c-Src regulation of fibroblast growth factor-induced proliferation in murine embryonic fibroblasts

Dawn M Kilkenny1, Jonathan V Rocheleau, James Price

  • 1Department of Medicine, Vanderbilt University School of Medicine, Nashville, Tennessee 37232, USA.

Insights

Fibroblast growth factor (FGF) and epidermal growth factor (EGF) signaling pathways require an optimal level of c-Src protein for cell proliferation. Too much or too little c-Src inhibits these growth factor responses.

Area of Science:

  • Cellular Biology
  • Molecular Signaling
  • Signal Transduction

Background:

  • Fibroblast growth factor receptor 1 (FGFR1) activation initiates intracellular signaling cascades.
  • The precise role of Src family kinases, particularly c-Src, in FGFR1 signaling remains unclear.

Purpose of the Study:

  • To investigate the impact of c-Src expression levels on fibroblast growth factor (FGF) signaling.
  • To determine if c-Src regulates other growth factor pathways, including epidermal growth factor (EGF), platelet-derived growth factor (PDGF), and lysophosphatidic acid (LPA).

Main Methods:

  • Comparison of FGF-induced proliferation in murine embryonic fibroblasts (MEFs) with varying c-Src expression (deficient, endogenous, overexpressed).
  • Analysis of c-Src-deficient MEFs transfected with varying levels of a c-Src expression vector.
  • Examination of cellular responses to EGF, PDGF, and LPA in MEFs with different c-Src levels.

Main Results:

  • MEFs with endogenous c-Src levels exhibited significantly greater FGF-induced DNA synthesis and proliferation compared to those lacking or overexpressing c-Src.
  • An optimal quantity of c-Src expression was identified for maximal FGF-induced proliferation.
  • FGF and EGF signaling responses were inhibited by c-Src deficiency or overexpression, while PDGF and LPA responses were largely unaffected.

Conclusions:

  • Mitogenic signaling pathways activated by FGF and EGF are regulated by c-Src protein levels, suggesting a critical "sweet spot" for optimal function.
  • The regulatory role of c-Src in growth factor signaling differs between FGF/EGF pathways and PDGF/LPA pathways.

Related Concept Videos

Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl hydroxylase and factor...
Regulation of Hematopoietic Stem Cells01:01

Regulation of Hematopoietic Stem Cells

All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
Introduction to Fibroblasts01:09

Introduction to Fibroblasts

Rudolph Virchow discovered spindle-shaped cells called fibroblasts in 1858. Inactive fibroblasts, called fibrocytes, become activated by various stimuli, such as growth factors and inflammatory cytokines. Activated fibroblasts play a crucial role in wound healing, inflammation, formation of new blood vessels, and cancer progression. Uncontrolled activation of fibroblasts results in fibrosis, the excess deposition of fibrous tissue, which can lead to scarring and affect normal organs. This...
TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors are of three kinds RI, RII, and RIII. The RI...